Pier Adelchi Ruffini

Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2

Arya Biragyn, Pier Adelchi Ruffini, Cynthia A. Leifer et al. · Science · 2002 · 890 citations

Life Sciences, Immunology, Infectious Diseases +17

Mediators of Innate Immunity That Target Immature, But Not Mature, Dendritic Cells Induce Antitumor Immunity When Genetically Fused with Nonimmunogenic Tumor Antigens

Arya Biragyn, Munhsuren Surenhu, De Yang et al. · The Journal of Immunology · 2001 · 287 citations · Full text

Life Sciences, Immunology, Oncology +17

Phase Ib Pilot Study to Evaluate Reparixin in Combination with Weekly Paclitaxel in Patients with HER-2–Negative Metastatic Breast Cancer

Anne F. Schott, Lori J. Goldstein, Massimo Cristofanilli et al. · Clinical Cancer Research · 2017 · 240 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer

Giuseppe Perrone, Pier Adelchi Ruffini, Vincenzo Catalano et al. · European Journal of Cancer · 2008 · 210 citations

Medicine, Immunology, Oncology +15

CXCR1/2 inhibition enhances pancreatic islet survival after transplantation

Antonio Citro, Elisa Cantarelli, Paola Maffi et al. · Journal of Clinical Investigation · 2012 · 149 citations · Full text

Life Sciences, Immunology, Pharmacology +17